Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
ARA-290 research-grade peptide, third-party tested with COA available (99%+ purity)
doi: 10.1002/art.27652 38 FleishakerDLGarcia MeijideJAPetrovAKohenMDWangXMenonSet al
The treatment involves drawing a blood sample, processing it to concentrate the platelets, and injecting the platelet-rich plasma into the affected joint
The numbers below assume the standard research-planning band of about 250 mcg twice daily from 10 mg vials reconstituted with 2 mL bacteriostatic water
Injection (including 96372) with Separate E/M All procedures are valued for reimbursement to include an assessment of the patient at the encounter (vital signs, appearance of the patient, etc.)
US$ 23.23
US$ 29.23
US$ 20.30
US$ 25.83
US$ 21.08
US$ 29.36
